The peroxisome proliferator WY-14,643 promotes hepatocarcinogenesis caused by endogenously generated oxidative DNA base modifications in repair-deficient Csbm/m/Ogg1-/- mice

Cancer Research

Volumn 67, Issue 11, 2007, Pages 5156-5161

  Trapp, Christian ^a   Schwarz, Michael ^b   Epe, Bernd ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BASE; GLUCOSE 6 PHOSPHATASE; PEROXISOME PROLIFERATOR; PIRINIXIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA MODIFICATION; GENE MUTATION; LIVER CARCINOGENESIS; LIVER CELL; MOUSE; MUTATION RATE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; COCARCINOGENESIS; DNA DAMAGE; DNA GLYCOSYLASES; DNA REPAIR; DNA REPAIR ENZYMES; GUANINE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MUTATION; OXIDATIVE STRESS; PEROXISOME PROLIFERATORS; PRECANCEROUS CONDITIONS; PYRIMIDINES;

EID: 34347242121     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0335     Document Type: Article

References (42)

1. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361-70.
2. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998;78:547-81.
3. Larsen E, Meza TJ, Kleppa L, Klungland A. Organ and cell specificity of base excision repair mutants in mice. Mutat Res 2007;614:56-68.
4. Klungland A, Rosewell I, Hollenbach S, et al. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci U S A 1999;96:13300-5.
5. Minowa O, Arai T, Hirano M, et al. Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci U S A 2000;97:4156-61.
6. Osterod M, Hollenbach S, Hengstler JG, Barnes DE, Lindahl T, Epe B. Age-related and tissue-specific accumulation of oxidative DNA base damage in 7,8-dihydro-8-oxoguanine-DNA glycosylase (Ogg1) deficient mice. Carcinogenesis 2001;22:1459-63.
7. van der Horst GT, van Steeg H, Berg RJ, et al. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 1997;89:425-35.
8. Trapp C, Reite K, Klungland A, Epe B. Deficiency of the Cockayne syndrome B (CSB) gene aggravates the genomic instability caused by endogenous oxidative DNA base damage in mice. Oncogene. Epub 2007 January 8. doi: 10.1038/sj.onc.120167.
9. Osterod M, Larsen E, Le Page F, et al. A global DNA repair mechanism involving the Cockayne syndrome B (CSB) gene product can prevent the in vivo accumulation of endogenous oxidative DNA base damage. Oncogene 2002;21:8232-9.
10. Dolle ME, Busuttil RA, Garcia AM, et al. Increased genomic instability is not a prerequisite for shortened lifespan in DNA repair deficient mice. Mutat Res 2006;596:22-35.
11. Xie Y, Yang H, Cunanan C, et al. Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res 2004;64:3096-102.
12. Reddy JK, Azarnoff DL, Hignite CE. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 1980;283:397-8.
13. Rao MS, Reddy JK. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis 1987;8:631-6.
14. Glauert HP, Beer D, Rao MS, et al. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine. Cancer Res 1986;46:4601-6.
15. Cattley RC, Popp JA. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cancer Res 1989;49:3246-51.
16. O'Brien ML, Spear BT, Glauert HP. Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis. Crit Rev Toxicol 2005;35:61-88.
17. Peters JM, Cheung C, Gonzalez FJ. Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand? J Mol Med 2005;83:774-85.
18. Klaunig JE, Babich MA, Baetcke KP, et al. PPARα agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol 2003;33:655-780.
19. Woods CG, Burns AM, Maki A, et al. Sustained formation of α-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-α, but not NADPH oxidase. Free Radic Biol Med 2007;42:335-42.
20. Galloway SM, Johnson TE, Armstrong MJ, Ashby J. The genetic toxicity of the peroxisome proliferator class of rodent hepatocarcinogen. Mutat Res 2000;448:153-8.
21. Yeldandi AV, Rao MS, Reddy JK. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat Res 2000;448:159-77.
22. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347:645-50.
23. Peters JM, Cattley RC, Gonzalez FJ. Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 1997;18:2029-33.
24. Ringhoffer M, Schmitt M, Karbach J, Jager E, Oesch F, Arand M. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction. Int J Oncol 2001;19:983-9.
25. Hengstler JG, Utesch D, Steinberg P, et al. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev 2000;32:81-118.
26. Kohn KW, Erickson LC, Ewig RA, Friedman CA. Fractionation of DNA from mammalian cells by alkaline elution. Biochemistry 1976;15:4629-37.
27. Epe B, Hegler J. Oxidative DNA damage: endonuclease fingerprinting. Methods Enzymol 1994;234:122-31.
28. Pflaum M, Will O, Epe B. Determination of steady-state levels of oxidative DNA base modifications in mammalian cells by means of repair endonucleases. Carcinogenesis 1997;18:2225-31.
29. Heinmoller PW, Hill KA, Sommer SS. High plating density improves Big Blue system efficiency without loss of sensitivity. Mutat Res 2000;453:97-103.
30. Nishino H, Buettner VL, Sommer SS. Towards validation of the Big Blue transgenic mouse mutagenesis assay: the mutational spectrum of ex vivo pinpoint mutant plaques. Mutat Res 1996;372:97-105.
31. Kohler SW, Provost GS, Fieck A, et al. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environ Mol Mutagen 1991;18:316-21.
32. Wachstein M, Meisel E. Histochemistry of hepatic phosphatases at a physiological pH. Am J Clin Pathol 1957;27:13-23.
33. Schwarz M, Buchmann A, Schulte M, Pearson D, Kunz W. Heterogeneity of enzyme-altered foci in rat liver. Toxicol Lett 1989;49:297-317.
34. Moennikes O, Stahl S, Bannasch P, Buchmann A, Schwarz M. WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice. Carcinogenesis 2003;24:1561-5.
35. Lawrence JW, Wollenberg GK, Frank JD, DeLuca JG. Dexamethasone selectively inhibits WY14,643-induced cell proliferation and not peroxisome proliferation in mice. Toxicol Appl Pharmacol 2001;170:113-23.
36. Krokan HE, Standal R, Slupphaug G. DNA glycosylases in the base excision repair of DNA. Biochem J 1997;325:1-16.
37. Pitot HC. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu Rev Pharmacol Toxicol 1990;30:465-500.
38. Rose ML, Rusyn I, Bojes HK, Belyea J, Cattley RC, Thurman RG. Role of Kupffer cells and oxidants in signaling peroxisome proliferator-induced hepatocyte proliferation. Mutat Res 2000;448:179-92.
39. Roglans N, Bellido A, Rodriguez C, et al. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver. Clin Pharmacol Ther 2002;72:692-701.
40. Cheung C, Akiyama TE, Ward JM, et al. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor α. Cancer Res 2004;64:3849-54.
41. Proietti-De-Santis L, Drane P, Egly JM. Cockayne syndrome B protein regulates the transcriptional program after UV irradiation. EMBO J 2006;25:1915-23.
42. ESCODD. Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus. Carcinogenesis 2002;23:2129-33.